Evidence map›Paper›PMID 31015445›Full record

ArticleNature communications2019

PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation.

Kei Miyakawa, Satoko Matsunaga, Masaru Yokoyama, Masako Nomaguchi, Yayoi Kimura, Mayuko Nishi, Hirokazu Kimura, Hironori Sato, Hisashi Hirano, Tomohiko Tamura and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Genome-Wide CRISPR Screen Identifies Host Factors Required byFrontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Kei MiyakawaDepartment of Microbiology, Yokohama City University School of Medicine, Kanagawa, 236-0004, Japan.
Satoko MatsunagaDepartment of Microbiology, Yokohama City University School of Medicine, Kanagawa, 236-0004, Japan.
Masaru YokoyamaPathogen Genomics Center, National Institute of Infectious Diseases, Musashi Murayama, Tokyo, 208-0011, Japan.ORCID http://orcid.org/0000-0003-1641-0365
Masako NomaguchiDepartment of Microbiology, Tokushima University Graduate School of Medical Science, Tokushima, 770-8503, Japan.
Yayoi KimuraAdvanced Medical Research Center, Yokohama City University, Kanagawa, 236-0004, Japan.
Mayuko NishiDepartment of Microbiology, Yokohama City University School of Medicine, Kanagawa, 236-0004, Japan.
Hirokazu KimuraSchool of Medical Technology, Faculty of Health Sciences, Gunma Paz University, Gunma, 370-0006, Japan.
Hironori SatoPathogen Genomics Center, National Institute of Infectious Diseases, Musashi Murayama, Tokyo, 208-0011, Japan.
Hisashi HiranoAdvanced Medical Research Center, Yokohama City University, Kanagawa, 236-0004, Japan.
Tomohiko TamuraDepartment of Immunology, Yokohama City University School of Medicine, Kanagawa, 236-0004, Japan.
Hirofumi AkariLaboratory of Infectious Disease Model, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
Tomoyuki MiuraCenter for Human Evolution Modeling Research, Primate Research Institute, Kyoto University, Aichi, 484-8506, Japan.
Akio AdachiDepartment of Microbiology, Tokushima University Graduate School of Medical Science, Tokushima, 770-8503, Japan.
Tatsuya SawasakiProteo-Science Center, Ehime University, Ehime, 790-8577, Japan.
Naoki YamamotoNational Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Akihide RyoDepartment of Microbiology, Yokohama City University School of Medicine, Kanagawa, 236-0004, Japan. aryo@yokohama-cu.ac.jp.
Yokohama City University · JPYokohama City University Medical Center · JPKyoto University · JPNational Institute of Infectious Diseases · JPEhime University · JPGumma Paz College · JPKansai Medical University · JPTokushima University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lentiviruses have evolved to acquire an auxiliary protein Vpx to counteract the intrinsic host restriction factor SAMHD1. Although Vpx is phosphorylated, it remains unclear whether such phosphorylation indeed regulates its activity toward SAMHD1. Here we identify the PIM family of serine/threonine protein kinases as the factors responsible for the phosphorylation of Vpx and the promotion of Vpx-mediated SAMHD1 counteraction. Integrated proteomics and subsequent functional analysis reveal that PIM family kinases, PIM1 and PIM3, phosphorylate HIV-2 Vpx at Ser13 and stabilize the interaction of Vpx with SAMHD1 thereby promoting ubiquitin-mediated proteolysis of SAMHD1. Inhibition of the PIM kinases promotes the antiviral activity of SAMHD1, ultimately reducing viral replication. Our results highlight a new mode of virus-host cell interaction in which host PIM kinases facilitate promotion of viral infectivity by counteracting the host antiviral system, and suggest a novel therapeutic strategy involving restoration of SAMHD1-mediated antiviral response.

Indexed as

Biphenyl CompoundsCell Line, TumorHEK293 CellsHIV-2HIV InfectionsHost-Pathogen InteractionsHumansImidazolesImmune ToleranceMolecular Dynamics SimulationMonocytesPhosphorylationProtein BindingProtein Kinase InhibitorsProtein Processing, Post-TranslationalProtein Serine-Threonine KinasesAZD1208Biphenyl CompoundsImidazolesPIM1 protein, humanPIM3 protein, humanProtein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-pim-1PyridazinesRecombinant ProteinsSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanSerineSGI 1776ThiazolidinesViral Regulatory and Accessory ProteinsVPX protein, Human immunodeficiency virus 2

Identifiers

PMID31015445
PMCPMC6479052
OpenAlexW2942069365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.